|
US2021093709A1
|
|
Use of shrek proteins for inactivating viral infectivity and to produce live-attenuated vaccines against viruses
|
|
US2021042089A1
|
|
Re-configurable and efficient neural processing engine powered by temporal carry differing multiplication and addition logic
|
|
WO2020264093A2
|
|
Diagnostic method for infectious diseases
|
|
US2020362307A1
|
|
Membrane coverage and orientation and methods, compositions, and kits related thereto
|
|
US2020363421A1
|
|
Molecularly imprinted particles
|
|
US2020317365A1
|
|
Systems and methods for improved aircraft safety
|
|
US2020316190A1
|
|
Psgl-1 (p-selectin glycoprotein ligand-1) to inactivate all enveloped viruses for producing live-attenuated vaccines
|
|
US2020297834A1
|
|
Alphavirus and compositions, methods, and kits related thereto
|
|
US2020175148A1
|
|
Collaborative context-aware visual authentication question protocol
|
|
US2020172570A1
|
|
Antimicrobial peptides and compositions, methods, articles & kits relating thereto
|
|
US2020036748A1
|
|
Secure overlay communication model for decentralized autonomous power grid
|
|
US2020026859A1
|
|
Methods and systems for system call reduction
|
|
US2019383823A1
|
|
Methods for discovering protein-protein interactions
|
|
US2019380964A1
|
|
Methods and compositions for making and using nanotherapeutic drug delivery vehicles
|
|
US2019365921A1
|
|
Method and System of Harvesting Extracellular Vesicles Using Hydrogel Particles for Later Delivery to, and Remodeling of, an Immune System
|
|
US10752642B1
|
|
Macrocyclic lactones
|
|
US2019320964A1
|
|
Systems and methods for biobehavioral-regulation treatments
|
|
US2019240318A1
|
|
Method and system for inactivating virus infectivity for producing live-attenuated vaccines
|
|
US2019189243A1
|
|
Mining All Atom Simulations for Diagnosing and Treating Disease
|
|
US2019169297A1
|
|
Targeting the cofilin pathway
|
